NO20042410L - Sammensetning som omfatter angiopoietinliknende protein 3, ANGPTL3 og fremgangsmate til anvendelse av samme - Google Patents

Sammensetning som omfatter angiopoietinliknende protein 3, ANGPTL3 og fremgangsmate til anvendelse av samme

Info

Publication number: NO20042410L
Authority: NO; Norway
Prior art keywords: angptl3; angiopoietin; protein; composition; same
Prior art date: 2001-11-16

Application number

NO20042410A

Other languages

English (en)

Other versions

NO336021B1 (no

Inventor

Napoleone Ferrara

Hans-Peter Gerber

Joe Kowalski

Maria Teresa Pisabarro

Daniel Eric Sherman

Original Assignee

Genentech Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-11-16

Filing date

2004-06-09

Publication date

2004-06-09

2004-06-09 Application filed by Genentech Inc filed Critical Genentech Inc

2004-06-09 Publication of NO20042410L publication Critical patent/NO20042410L/no

2015-04-20 Publication of NO336021B1 publication Critical patent/NO336021B1/no

Links

102100025668 Angiopoietin-related protein 3 Human genes 0.000 title 2
101710085848 Angiopoietin-related protein 3 Proteins 0.000 title 1
101000693085 Homo sapiens Angiopoietin-related protein 3 Proteins 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/515—Angiogenesic factors; Angiogenin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Virology (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Immunology (AREA)
Molecular Biology (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
Biophysics (AREA)
Zoology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Diabetes (AREA)
Genetics & Genomics (AREA)
Cardiology (AREA)
Obesity (AREA)
Biochemistry (AREA)
Heart & Thoracic Surgery (AREA)
Toxicology (AREA)
Rheumatology (AREA)
Mycology (AREA)
Biotechnology (AREA)
Pain & Pain Management (AREA)
Urology & Nephrology (AREA)
Child & Adolescent Psychology (AREA)
Microbiology (AREA)

NO20042410A 2001-11-16 2004-06-09 Anvendelse av en antagonist av Angptl3 til fremstilling av et medikament for behandling eller forebygging av vevsskade forbundet med en inflammatorisk leversykdom, og en antagonist av Angptl3 for nevnte anvendelse. NO336021B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US33242901P	2001-11-16	2001-11-16
PCT/US2002/036865 WO2003044172A2 (en)	2001-11-16	2002-11-13	Composition comprising and method of using angiopoietin-like protein 3 angptl3

Publications (2)

Publication Number	Publication Date
NO20042410L true NO20042410L (no)	2004-06-09
NO336021B1 NO336021B1 (no)	2015-04-20

Family

ID=23298191

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20042410A NO336021B1 (no)	2001-11-16	2004-06-09	Anvendelse av en antagonist av Angptl3 til fremstilling av et medikament for behandling eller forebygging av vevsskade forbundet med en inflammatorisk leversykdom, og en antagonist av Angptl3 for nevnte anvendelse.

Country Status (14)

Country	Link
US (3)	US7267819B2 (no)
EP (1)	EP1451578B1 (no)
JP (2)	JP5105696B2 (no)
KR (2)	KR20100029861A (no)
CN (2)	CN1615440A (no)
AU (1)	AU2002348286B2 (no)
CA (1)	CA2464542C (no)
ES (1)	ES2429034T3 (no)
IL (2)	IL161542A0 (no)
MX (1)	MXPA04004609A (no)
NO (1)	NO336021B1 (no)
NZ (1)	NZ532852A (no)
WO (1)	WO2003044172A2 (no)
ZA (1)	ZA200403070B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20050123925A1 (en)	2002-11-15	2005-06-09	Genentech, Inc.	Compositions and methods for the diagnosis and treatment of tumor
KR20100029861A (ko)	2001-11-16	2010-03-17	제넨테크, 인크.	안지오포이에틴-유사 단백질 3 ａｎｇｐｔｌ3을 함유하는 조성물 및 이를 사용하는 방법
CN1835759B (zh) *	2003-08-21	2012-05-02	达切斯内公司	微量营养素补充剂
HUE029170T2 (en) *	2004-07-20	2017-03-28	Genentech Inc	Preparations and methods for the use of angiopoietin-like protein 4
US8604185B2 (en)	2004-07-20	2013-12-10	Genentech, Inc.	Inhibitors of angiopoietin-like 4 protein, combinations, and their use
SI1771474T1 (sl) *	2004-07-20	2010-06-30	Genentech Inc	Inhibitorji angiopoetinu podobnega proteina kombinacije in njihova uporaba
US7807645B2 (en)	2005-09-23	2010-10-05	The Regents Of The University Of California	Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment
ZA200904022B (en)	2006-12-08	2010-08-25	Lexicon Pharmaceuticals Inc	Monoclonal antibodies against ANGPTL3
US8354111B2 (en)	2008-04-14	2013-01-15	Hadasit Medical Research Services And Development Ltd.	Stable cell binding chimeric peptides
CN101852805B (zh) *	2009-03-31	2015-04-01	浙江大学	Angptl3作为卵巢癌的诊断标记物的用途
PE20160507A1 (es) *	2009-07-14	2016-05-20	Scripps Research Inst	Diferenciacion de celulas madre mesenquimales
AU2015200969A1 (en) *	2010-01-08	2015-03-19	Ionis Pharmaceuticals, Inc.	Modulation of angiopoietin-like 3 expression
WO2011085271A2 (en)	2010-01-08	2011-07-14	Isis Pharmaceuticals, Inc.	Modulation of angiopoietin-like 3 expression
JP5838474B2 (ja) *	2010-02-02	2016-01-06	アリゾナボードオブリージェンツオンビハーフオブアリゾナステートユニバーシティ	ポリマーの配列を決定するための制御されたトンネルギャップデバイス
EP2668499A4 (en) *	2011-01-29	2015-05-27	Astute Medical Inc	METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
AR087329A1 (es)	2011-06-17	2014-03-19	Regeneron Pharma	Anticuerpos humanos contra proteina 3 de tipo angiopoietina humana
CN104271590B (zh)	2012-01-24	2018-06-05	Inter-K私人有限公司	用于癌治疗的肽剂
US9301971B2 (en)	2013-03-08	2016-04-05	Novartis Ag	Peptides and compositions for treatment of joint damage
UY35368A (es)	2013-03-08	2014-10-31	Irm Llc	Péptidos y composiciones para el tratamiento de daño articular
CN104062432B (zh) *	2013-03-22	2016-01-20	中山大学	ang2在制备ECTC血管类型肝癌诊断试剂及治疗药物中的应用
PL2992098T3 (pl)	2013-05-01	2019-09-30	Ionis Pharmaceuticals, Inc.	Kompozycje i sposoby modulowania ekspresji hbv i ttr
PL3087183T3 (pl)	2013-12-24	2021-01-11	Ionis Pharmaceuticals, Inc.	Modulacja ekspresji białka angiopoetynopodobnego 3
WO2015168589A2 (en)	2014-05-01	2015-11-05	Isis Pharmaceuticals, Inc.	Compositions and methods for modulating angiopoietin-like 3 expression
CN105021827B (zh) *	2015-07-17	2016-09-28	北京大学第一医院	检测血清血管生成素样蛋白2含量的物质在制备检测肝脏炎症和纤维化程度产品中的应用
AU2016349625B2 (en)	2015-11-06	2022-07-07	Ionis Pharmaceuticals, Inc.	Modulating apolipoprotein (a) expression
WO2017136712A1 (en) *	2016-02-04	2017-08-10	Regeneron Pharmaceuticals, Inc.	Non-human animals having an engineered angptl8 gene
MA43734A (fr)	2016-03-03	2018-11-28	Regeneron Pharma	Procédés de traitement de patients atteints d'hyperlipidémie par administration d'un inhibiteur de pcsk9 en combinaison avec un inhibiteur d'angptl3
MX2020001912A (es) *	2017-09-14	2020-03-24	Arrowhead Pharmaceuticals Inc	Agentes de iarn y composiciones para inhibir la expresion de la angiopoyetina tipo 3 (angptl3) y metodos de uso.
TW202027794A (zh)	2018-10-03	2020-08-01	瑞士商諾華公司	血管生成素樣３多肽之持續遞送
WO2020099482A2 (en) *	2018-11-13	2020-05-22	Lipigon Pharmaceuticals Ab	Angptl 3 oligonucleotides influencing the regulation of the fatty acid metabolism
TWI747098B (zh) *	2018-12-21	2021-11-21	美商美國禮來大藥廠	抗angptl3/8複合物抗體及其使用方法
US12559551B2 (en)	2019-05-24	2026-02-24	Regeneron Pharmaceuticals, Inc.	Stabilized formulations containing anti-ANGPTL3 antibodies
US20220380425A1 (en) *	2019-07-04	2022-12-01	Cadila Healthcare Limited	Angptl3 based vaccine for the treatment of liver disease
CN111122872B (zh) *	2019-11-20	2023-01-20	中山大学附属第一医院	血管生成素样蛋白7在心力衰竭预后评估中的应用
CN110938144B (zh) *	2019-11-27	2022-07-26	复旦大学附属儿科医院	一种抗angptl3单克隆抗体及其在制备治疗肾病综合征药物中的用途
WO2022187353A1 (en) *	2021-03-05	2022-09-09	Anji Pharmaceuticals Inc.	Methods and compositions for treating sepsis
CN114934021B (zh) *	2022-04-21	2023-08-08	复旦大学附属儿科医院	一种Angptl3敲除的鼠永生化足细胞系及其应用
CN120254294B (zh) *	2025-06-05	2025-09-09	南昌大学第一附属医院	Angptl3在乙肝相关慢加急性肝衰竭预后中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6596850B1 (en) *	1998-01-30	2003-07-22	Ixsys, Incorporated	Anti-αv3β3 recombinant human antibodies, nucleic acids encoding same
CA2252629A1 (en)	1997-02-26	1998-09-03	Toray Industries, Inc.	Remedies for hepatitis
US5972338A (en) *	1997-09-19	1999-10-26	Genentech, Inc.	Tie ligands homologues
US6030831A (en) *	1997-09-19	2000-02-29	Genetech, Inc.	Tie ligand homologues
WO1999055869A1 (en) *	1998-04-27	1999-11-04	Zymogenetics, Inc.	Novel polypeptide growth factors and materials and methods for making them
EP1078046A4 (en) *	1998-05-12	2005-05-11	Human Genome Sciences Inc	97 HUMAN SECRETED PROTEINS
AU4643699A (en) *	1998-06-24	2000-01-10	Compugen Ltd.	Angiopoietin-like growth factor sequences
JP2003531811A (ja) *	1999-03-08	2003-10-28	ジェネンテック・インコーポレーテッド	血管形成及び心臓血管新生の促進又は阻害
KR20100029861A (ko) *	2001-11-16	2010-03-17	제넨테크, 인크.	안지오포이에틴-유사 단백질 3 ａｎｇｐｔｌ3을 함유하는 조성물 및 이를 사용하는 방법

2002
- 2002-11-13 KR KR1020107004734A patent/KR20100029861A/ko not_active Ceased
- 2002-11-13 IL IL16154202A patent/IL161542A0/xx not_active IP Right Cessation
- 2002-11-13 ES ES02782310T patent/ES2429034T3/es not_active Expired - Lifetime
- 2002-11-13 NZ NZ532852A patent/NZ532852A/en not_active IP Right Cessation
- 2002-11-13 EP EP02782310.3A patent/EP1451578B1/en not_active Expired - Lifetime
- 2002-11-13 AU AU2002348286A patent/AU2002348286B2/en not_active Ceased
- 2002-11-13 KR KR1020047007410A patent/KR101012904B1/ko not_active Expired - Fee Related
- 2002-11-13 CN CNA028271920A patent/CN1615440A/zh active Pending
- 2002-11-13 CN CN2010102426068A patent/CN101905024A/zh active Pending
- 2002-11-13 WO PCT/US2002/036865 patent/WO2003044172A2/en not_active Ceased
- 2002-11-13 MX MXPA04004609A patent/MXPA04004609A/es active IP Right Grant
- 2002-11-13 JP JP2003545797A patent/JP5105696B2/ja not_active Expired - Fee Related
- 2002-11-13 CA CA2464542A patent/CA2464542C/en not_active Expired - Fee Related
- 2002-11-15 US US10/298,461 patent/US7267819B2/en not_active Expired - Lifetime
2004
- 2004-04-22 ZA ZA2004/03070A patent/ZA200403070B/en unknown
- 2004-06-09 NO NO20042410A patent/NO336021B1/no not_active IP Right Cessation
2006
- 2006-09-29 US US11/537,567 patent/US20070134250A1/en not_active Abandoned
2008
- 2008-05-28 US US12/128,545 patent/US8541376B2/en not_active Expired - Fee Related
2009
- 2009-11-13 JP JP2009259497A patent/JP2010100624A/ja active Pending
2010
- 2010-02-11 IL IL203894A patent/IL203894A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
US20030215451A1 (en)	2003-11-20
CA2464542C (en)	2015-01-20
NO336021B1 (no)	2015-04-20
JP2010100624A (ja)	2010-05-06
US7267819B2 (en)	2007-09-11
CN101905024A (zh)	2010-12-08
EP1451578B1 (en)	2013-08-21
WO2003044172B1 (en)	2004-03-18
CA2464542A1 (en)	2003-05-30
AU2002348286A1 (en)	2003-06-10
WO2003044172A2 (en)	2003-05-30
ZA200403070B (en)	2005-06-29
JP5105696B2 (ja)	2012-12-26
KR20100029861A (ko)	2010-03-17
CN1615440A (zh)	2005-05-11
US20070134250A1 (en)	2007-06-14
JP2005521643A (ja)	2005-07-21
ES2429034T3 (es)	2013-11-12
EP1451578A4 (en)	2006-02-01
AU2002348286B2 (en)	2008-04-03
IL161542A0 (en)	2004-09-27
WO2003044172A3 (en)	2003-11-20
EP1451578A2 (en)	2004-09-01
KR101012904B1 (ko)	2011-02-08
KR20050044485A (ko)	2005-05-12
US20090098117A1 (en)	2009-04-16
US8541376B2 (en)	2013-09-24
IL203894A (en)	2013-09-30
NZ532852A (en)	2006-08-31
MXPA04004609A (es)	2004-08-12

Legal Events

Date	Code	Title	Description
2021-06-28	MM1K	Lapsed by not paying the annual fees

Publication	Publication Date	Title
NO20012158D0 (no)	2001-05-02	Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
DK0965578T3 (da)	2003-07-21	Hidtil ukendt triglycerik og præparat, som omfatter dette
MXPA03006775A (es)	2003-10-24	Formulacion farmaceutica.
DE60202270D1 (de)	2005-01-20	4,5-dihydro-1h-pyrazolderivate mit cb1-antagonistischer wirkung
MXPA03007641A (es)	2003-12-04	Formulacion farmaceutica.
CY2009017I1 (el)	2012-01-25	Μεθοδος για την παρασκευη 10, 11-διυδρο-10-υδροξυ-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου και 10,11-διυδρο-10-οξο-5η-διβενζο/β,f/αζεπινο-5-καρβοξαμιδιου
MXPA03007827A (es)	2003-12-08	Metodo y composicion para la coloracion permanente gradual de cabello.
NO20010326D0 (no)	2001-01-19	FSH og FSH-variantformuleringer, produkter og fremgangsmåter
AU2002360733A8 (en)	2003-07-24	Substituted 4,9-dihydrocyclopenta(imn)phenanthridine-5-ones derivatives thereof and their uses
HUP0402385A3 (en)	2005-10-28	5-phenylpyrimidines, fungicide compositions comprising the same, method for producing and use thereof
BR0209195B1 (pt)	2012-07-10	aquecedor para pirólise e método para operar o mesmo.
NO20040860L (no)	2004-04-22	Farmasoytisk sammensetning som innbefatter lumiracoxib
ZA200206779B (en)	2003-04-15	Solid formulation.
NO984444D0 (no)	1998-09-24	Benzothiofener, formuleringer som inneholder de samme, og fremgangsmÕter
MA26666A1 (fr)	2004-12-20	Antioxide, composition antiproliferee, y compris carnitine et carotenoide.
ATE369137T1 (de)	2007-08-15	Lyophilisierte formulierung enthaltend olanzapin
DK0791591T3 (da)	2001-10-08	Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling
DK0811593T3 (da)	2002-09-02	1,4-diaryl-2-flour-2-buten som insektcider og acaricider
GB0217548D0 (en)	2002-09-11	Four human zinc-finger-containing proteins:MDZ3.MDZ4,MDZ7 and MDZ12
DK1053224T3 (da)	2002-12-23	Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
DE60220799D1 (de)	2007-08-02	Hypoglykämisches mittel
EP1389204A4 (en)	2005-03-23	NEW SULPHONAMIDE DERIVATIVES, THEIR INTERMEDIATES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THESE COMPOUNDS
DE50107204D1 (de)	2005-09-29	8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
ITTO20020747A1 (it)	2003-02-25	Composizione.
PT1408035E (pt)	2006-05-31	Metodo de preparacao de derivativos de 1.5-diaril-3-trifluorometilo-delta2-pirazolinas que sejam racemicos e enanciomericamente puros